ID D8LXQ8_BLAHO Unreviewed; 1769 AA.
AC D8LXQ8;
DT 05-OCT-2010, integrated into UniProtKB/TrEMBL.
DT 05-OCT-2010, sequence version 1.
DT 08-NOV-2023, entry version 54.
DE SubName: Full=Uncharacterized protein {ECO:0000313|EMBL:CBK20363.2};
GN ORFNames=GSBLH_T00000711001 {ECO:0000313|EMBL:CBK20363.2};
OS Blastocystis hominis.
OC Eukaryota; Sar; Stramenopiles; Bigyra; Opalozoa; Opalinata; Blastocystidae;
OC Blastocystis.
OX NCBI_TaxID=12968 {ECO:0000313|EMBL:CBK20363.2};
RN [1] {ECO:0000313|EMBL:CBK20363.2}
RP NUCLEOTIDE SEQUENCE.
RC STRAIN=Singapore isolate B {ECO:0000313|EMBL:CBK20363.2};
RA Wincker P.;
RT "Sequencing and annotation of the Blastocystis hominis genome.";
RL Submitted (FEB-2010) to the EMBL/GenBank/DDBJ databases.
CC -!- COFACTOR:
CC Name=FAD; Xref=ChEBI:CHEBI:57692;
CC Evidence={ECO:0000256|ARBA:ARBA00001974};
CC -!- COFACTOR:
CC Name=FMN; Xref=ChEBI:CHEBI:58210;
CC Evidence={ECO:0000256|ARBA:ARBA00001917};
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; FN668639; CBK20363.2; -; Genomic_DNA.
DR RefSeq; XP_012894411.1; XM_013038957.1.
DR EnsemblProtists; CBK20363; CBK20363; GSBLH_T00000711001.
DR GeneID; 24918006; -.
DR InParanoid; D8LXQ8; -.
DR OMA; THCNICA; -.
DR OrthoDB; 276396at2759; -.
DR Proteomes; UP000008312; Unassembled WGS sequence.
DR GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW.
DR GO; GO:0010181; F:FMN binding; IEA:InterPro.
DR GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR GO; GO:0016903; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors; IEA:InterPro.
DR GO; GO:0030976; F:thiamine pyrophosphate binding; IEA:InterPro.
DR GO; GO:0022900; P:electron transport chain; IEA:InterPro.
DR CDD; cd03377; TPP_PFOR_PNO; 1.
DR CDD; cd07034; TPP_PYR_PFOR_IOR-alpha_like; 1.
DR Gene3D; 3.30.70.20; -; 1.
DR Gene3D; 3.40.50.360; -; 1.
DR Gene3D; 3.40.50.920; -; 1.
DR Gene3D; 3.40.50.970; -; 2.
DR Gene3D; 3.40.50.80; Nucleotide-binding domain of ferredoxin-NADP reductase (FNR) module; 1.
DR Gene3D; 3.40.920.10; Pyruvate-ferredoxin oxidoreductase, PFOR, domain III; 1.
DR Gene3D; 4.10.780.10; Pyruvate-flavodoxin oxidoreductase, EKR domain; 1.
DR Gene3D; 2.40.30.10; Translation factors; 1.
DR InterPro; IPR017896; 4Fe4S_Fe-S-bd.
DR InterPro; IPR017900; 4Fe4S_Fe_S_CS.
DR InterPro; IPR003097; CysJ-like_FAD-binding.
DR InterPro; IPR017927; FAD-bd_FR_type.
DR InterPro; IPR001094; Flavdoxin-like.
DR InterPro; IPR008254; Flavodoxin/NO_synth.
DR InterPro; IPR001709; Flavoprot_Pyr_Nucl_cyt_Rdtase.
DR InterPro; IPR029039; Flavoprotein-like_sf.
DR InterPro; IPR039261; FNR_nucleotide-bd.
DR InterPro; IPR023173; NADPH_Cyt_P450_Rdtase_alpha.
DR InterPro; IPR001433; OxRdtase_FAD/NAD-bd.
DR InterPro; IPR033412; PFOR_II.
DR InterPro; IPR037112; Pyrv-flavodox_OxR_EKR_sf.
DR InterPro; IPR019456; Pyrv-flavodox_OxRtase_EKR.
DR InterPro; IPR019752; Pyrv/ketoisovalerate_OxRed_cat.
DR InterPro; IPR002880; Pyrv_Fd/Flavodoxin_OxRdtase_N.
DR InterPro; IPR011895; Pyrv_flavodox_OxRed.
DR InterPro; IPR002869; Pyrv_flavodox_OxRed_cen.
DR InterPro; IPR017938; Riboflavin_synthase-like_b-brl.
DR InterPro; IPR029061; THDP-binding.
DR InterPro; IPR011766; TPP_enzyme_TPP-bd.
DR InterPro; IPR009014; Transketo_C/PFOR_II.
DR NCBIfam; TIGR02176; pyruv_ox_red; 1.
DR PANTHER; PTHR32154; PYRUVATE-FLAVODOXIN OXIDOREDUCTASE-RELATED; 1.
DR PANTHER; PTHR32154:SF0; PYRUVATE-FLAVODOXIN OXIDOREDUCTASE-RELATED; 1.
DR Pfam; PF10371; EKR; 1.
DR Pfam; PF00667; FAD_binding_1; 1.
DR Pfam; PF12838; Fer4_7; 1.
DR Pfam; PF00258; Flavodoxin_1; 1.
DR Pfam; PF00175; NAD_binding_1; 1.
DR Pfam; PF17147; PFOR_II; 1.
DR Pfam; PF01558; POR; 1.
DR Pfam; PF01855; POR_N; 1.
DR Pfam; PF02775; TPP_enzyme_C; 1.
DR PRINTS; PR00369; FLAVODOXIN.
DR PRINTS; PR00371; FPNCR.
DR SMART; SM00890; EKR; 1.
DR SUPFAM; SSF54862; 4Fe-4S ferredoxins; 1.
DR SUPFAM; SSF52343; Ferredoxin reductase-like, C-terminal NADP-linked domain; 1.
DR SUPFAM; SSF52218; Flavoproteins; 1.
DR SUPFAM; SSF53323; Pyruvate-ferredoxin oxidoreductase, PFOR, domain III; 1.
DR SUPFAM; SSF63380; Riboflavin synthase domain-like; 1.
DR SUPFAM; SSF52518; Thiamin diphosphate-binding fold (THDP-binding); 2.
DR SUPFAM; SSF52922; TK C-terminal domain-like; 1.
DR PROSITE; PS00198; 4FE4S_FER_1; 2.
DR PROSITE; PS51379; 4FE4S_FER_2; 2.
DR PROSITE; PS51384; FAD_FR; 1.
DR PROSITE; PS50902; FLAVODOXIN_LIKE; 1.
PE 4: Predicted;
KW 4Fe-4S {ECO:0000256|ARBA:ARBA00022485};
KW Electron transport {ECO:0000256|ARBA:ARBA00022982};
KW FAD {ECO:0000256|ARBA:ARBA00022827};
KW Flavoprotein {ECO:0000256|ARBA:ARBA00022630};
KW FMN {ECO:0000256|ARBA:ARBA00022643}; Iron {ECO:0000256|ARBA:ARBA00023004};
KW Iron-sulfur {ECO:0000256|ARBA:ARBA00023014};
KW Metal-binding {ECO:0000256|ARBA:ARBA00022723};
KW NADP {ECO:0000256|ARBA:ARBA00022857};
KW Oxidoreductase {ECO:0000256|ARBA:ARBA00023002};
KW Reference proteome {ECO:0000313|Proteomes:UP000008312};
KW Signal {ECO:0000256|SAM:SignalP};
KW Transport {ECO:0000256|ARBA:ARBA00022448}.
FT SIGNAL 1..16
FT /evidence="ECO:0000256|SAM:SignalP"
FT CHAIN 17..1769
FT /evidence="ECO:0000256|SAM:SignalP"
FT /id="PRO_5003117613"
FT DOMAIN 683..712
FT /note="4Fe-4S ferredoxin-type"
FT /evidence="ECO:0000259|PROSITE:PS51379"
FT DOMAIN 740..769
FT /note="4Fe-4S ferredoxin-type"
FT /evidence="ECO:0000259|PROSITE:PS51379"
FT DOMAIN 1201..1343
FT /note="Flavodoxin-like"
FT /evidence="ECO:0000259|PROSITE:PS50902"
FT DOMAIN 1380..1612
FT /note="FAD-binding FR-type"
FT /evidence="ECO:0000259|PROSITE:PS51384"
SQ SEQUENCE 1769 AA; 195572 MW; FCD17298EB41848A CRC64;
MMLLLMLRTC LRWAFPYRYQ FCDNCFIYPI TPSTPMATNC DAYASRGMKN VFGQVGTVVE
MQSEAGASGA VHGALVGGGL CSTFTCSQGL LLMIPNMYKI AGEMLPCVFH VSARSVAGQA
LCIYGEHSDI MACRSTGFSF LCSQSVQEAH DIALCAHIAS LRASLPFVHF FDGFRTSHET
TNIRVIDEES MKQFVPWEAV RRHRARAVNP NHPDLRGTAQ SPDIYMQCVE AGNAAYTQVP
EIVDKVFEEM APVFGRRYRL FEYYGAEDAE DVVVCMGSGA NVVHETANYL NARGSKVGVL
KVRLFRPWSV KHFLEVLPKT VKRIAVLDRS KDAAAIGEPL YLDVCTSFST GETELRPMII
GGRYGLGSKD FTPGQAMSVF QNLRAEKPIR SFSVGINDDV TYRSLPQLPE PDTVPAGIYQ
AIMWGMGSDG TVSVSKTIMK ILGDYHNLNV QGYSEYEAKK SNGWSVNYLR YGKEPIDCPY
NIRCADYVSC SKSSYLYKFD MFSALKENGI FLLNTSATTL EEMEALLPGK AKRILARKNA
RLFVVDATAL AGKYHLGKYV NTTMGIVYFK LTGCMDVEEV VPIMKKMVEK TYIKKGEHIV
RNNWDCIDNS LEAVHQIEYP REAWMNAEVE KPHEIEGAPE FVNKVMLPIV RYEGDNLPVS
VFRPGGVMPS GTTRYEKRGI AIMNPEWQID KCIQCNQCAT VCPHACIRPV LLTEEEAAKA
PEGFKTLKAT GGGALNNMRF RIQVSPLDCT GCQLCVEACG DDALVMKDFE VMKTQEAANW
EYAMTVPSKG DLVGRNDVRS VQFHQPMLEF SGACDGCGET PYVKLITQLF GERMNIANAT
GCSSIWGGTA SFNPYTHNAR GQGPAWANSL FEDNAEYGLG MSVSVSQRRR VLRENVEALL
KEEAATLPEG LADLLAEWLE NYSDGRRCQS VANQVMDVLS GLEGKEVSAK LAAVIRDRDL
FPKISQWIIG GDGWAYDIGY GGVDHVLSTG EDVNIVVLDT EMYSNTGGQK SKATPMSAVQ
QFAAGGKFTH KKEMGLMAMS YRNVYVASVA LYADMAQAIR AFNEAESYNG PSIIFCYCPC
LMQNVVPAMR ATFKEVELAV KSGYWPLYRY DPRLSANGKN AFQLDYKKDL SDDLKNFLAN
ERRFLELNRT RPQVAEELHA ELKNHLQERH DDFVRRAMPL AKLAAASATS SGSGSGSSYE
LTILYGSETN HSKDLALTLM QEAEARQVEV TVNELDEMSM EDLATKKHVV ILCSTAGNGE
FPKNAKAFFA EASKEHPSDL LKNVEIHVFG LGDSSFANYN AAAKQIHARL QALGAKSIDL
TLANDQDPER YMTAWENWVP VFWEQSGVPE PVYEGVPPSN FAVSVKDASA HVSRRRFLPG
DAQLIPLVKK TRMTPVDYDR NIMHLVFDLD KTDIRYKVGD ALAIYPKNTD ALVQRFCAYL
AQDAETIVGI ASSSESLADK FPKTTTVGKI AAEILDLAGR PSRKLFKTMS YFAEGDEAAQ
LAALSRGEGE LAQRFAAETA SVMDVLEHFR CRVDLAHLLE VVPAIKPRLY SIASSQLRDP
HLLELCIVVN TWKTASGAEK TGLCTGYLDG LDLSNGPVQV AVSVNGGALF MPEDSSAPLL
MAGLGTGIAP FRAFVQEKAV QKHSGKTIGD VVFMMGLRYR AKEFLFGEEF EALEKEGVIS
HLLPAFSRDQ AQKVYIQHKV EENPALVCDV LVEKKGYFFY CGPAGSVPTA IEKAILKAFE
SVYKKSEQEA MDMLNSIKNE GRYVVEAWS
//